Research.Patient.info
Booster immunisation against COVID-19 disease caused by SARS-COV-2 Virus research hub
2 indexed studies · 2 currently recruiting
- recruitingHuman Pharmacology (Phase I)- Other
Effect of COV2 vaccine formulation on the ability to generate antibodies against coronavirus
This early-stage clinical trial looks at a new COVID-19 booster vaccine recipe. Researchers want to see how safe it is and how well it helps the immune system produce infection-fighting proteins called antibodies. It is open to adults aged 18 and over who want to help improve future vaccines.
Finland - recruitingHuman Pharmacology (Phase I)- First administration to humans
The safety and antibody response of the nasal COV2 vaccine against the SARS-CoV-2 virus
This study is testing a new nose spray vaccine for COVID-19. It's the very first time it's being given to people. Researchers want to see if it's safe and if it helps your body make protection against the COVID-19 virus, working as a booster.
Finland